SMC1A and acute myeloid leukemia: There were neither differences in baseline clinical characteristics between patients with SMC1A-mutated vs. SMC1A-wild-type AML (Table S12) nor between patients with SMC3-mutated vs. SMC3-wild-type AML (Table S13).